| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$37 |
Investor Presentation
|
31 Oct 2025 9:07AM |
$0.046 |
$0.175 |
risen by
280.43%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- 115,000 contracted licenses with $5.6 million ARR.
- FDA De Novo clearance for PainChek app in the US.
- Expansion into infant care with the PainChek Infant app.
- Regulatory clearance in ANZ, EU, and pending in the US.
- Projected ARR target covers core operating costs in ANZ and UK.
- Strong pipeline of 47,000 new licenses.
- Focus on B2C and B2B markets for global market penetration.
- PainChek Ltd is targeting an operational break-even point in ANZ and UK.
- Consistent growth in clinical utility and world's largest pain database.
- Strategic partnerships and integrations with major healthcare systems.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$843 |
AGM - Chair's Address and Presentation
|
31 Oct 2025 9:07AM |
$2.480 |
$2.260 |
fallen by
8.87%
|
|
| Globe Metals & Mining Limited (GBE) ORDINARY FULLY PAID |
Materials |
$56 |
Appendix 4G and Corporate Governance Statement
|
31 Oct 2025 9:06AM |
$0.049 |
$0.060 |
risen by
22.45%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$37 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:06AM |
$0.046 |
$0.175 |
risen by
280.43%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA De Novo clearance for PainChek Adult App in the US.
- Entry into the $175 million annual US long-term care market.
- 115,770 contracted licenses globally with an ARR of $5.6 million.
- Cash reserves of $6.3 million as of 30 September 2025.
- First US commercial agreement signed post-FDA clearance.
- PainChek Infant App targets $15 billion global market opportunity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$425 |
September 2025 Quarterly Activity Report and Appendix 4C
|
31 Oct 2025 9:06AM |
$3.500 |
$2.340 |
fallen by
33.14%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Discovery and filing of three patents for (E,E)-isoform of bisantrene.
- Phase 1 cardioprotection and anticancer trial of RC220 is ongoing.
- Regulatory approvals received in Hong Kong and South Korea.
- Cash and equivalents of $11.27 million as of September 2025.
- Significant focus on R&D and drug manufacturing.
- Additional $3.6 million funding raised through option conversions.
- (E,E)-bisantrene's mechanism involves G-quadruplex binding affecting cancer genes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pathkey.AI Ltd (PKY) ORDINARY FULLY PAID |
Information Technology |
$17 |
Quarterly Activities & Cashflow Report
|
31 Oct 2025 9:06AM |
$0.020 |
$0.028 |
risen by
40%
|
|
PKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Pathkey.AI's core platform, TrialKey, improves clinical trial success rates using AI.
- Cash position at the end of the quarter was $334,000.
- Net cash used in operating activities was $236,000.
- No cash receipts from customers during the quarter.
- Company plans to raise additional capital through equity securities.
- Pathkey is focusing on expanding market engagement and AI capabilities.
- Investments in AI-driven drug discovery and compound repurposing are ongoing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Globe Metals & Mining Limited (GBE) ORDINARY FULLY PAID |
Materials |
$56 |
Annual Report to Shareholders
|
31 Oct 2025 9:05AM |
$0.049 |
$0.060 |
risen by
22.45%
|
|
| Nuchev Limited (NUC) ORDINARY FULLY PAID |
Consumer Staple |
$20 |
Corporate Governance Statement and Appendix 4G
|
31 Oct 2025 9:05AM |
$0.140 |
$0.125 |
fallen by
10.71%
|
|
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$80 |
Q1 FY26 Results Presentation
|
31 Oct 2025 9:05AM |
$0.295 |
$0.340 |
risen by
15.25%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Mach7 Technologies reports Q1 FY26 financial highlights.
- CARR reached A$29.6 million, with a TCV of A$2.6 million.
- Closing cash reported at A$18.9 million with no debt.
- Focus on commercial transformation and operational efficiencies.
- Building intelligent imaging ecosystems and leveraging AI.
- Product innovation includes a new tele-imaging platform.
- Targeting growth in radiology, cardiology, and oncology markets.
- Emphasizing profitable growth through innovation and accountability.
- Share buy-back program paused pending strategic review.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nuchev Limited (NUC) ORDINARY FULLY PAID |
Consumer Staple |
$20 |
Annual Report to Shareholders
|
31 Oct 2025 9:05AM |
$0.140 |
$0.125 |
fallen by
10.71%
|
|
| Cuscal Limited (CCL) ORDINARY FULLY PAID |
Financials |
$810 |
Results of 2025 AGM
|
31 Oct 2025 9:04AM |
$4.150 |
$4.230 |
risen by
1.93%
|
|
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$11 |
Quarterly Activities Report
|
31 Oct 2025 9:04AM |
$0.039 |
$0.038 |
fallen by
2.56%
|
|
TEE - Price-sensitive ASX Announcement
Full Release
Key Points
- Top End Energy Limited reported its activities for the quarter ending 30 September 2025.
- The company is advancing discussions for its Serpentine Natural Hydrogen Project in Kansas, USA.
- Top End Energy is focused on the Beetaloo Basin in Northern Territory, Australia, with strategic partner discussions underway.
- The company has undertaken substantive oil and gas exploration activities totaling approximately A$909,000.
- Top End Energy's cash balance was approximately A$2,554,000 as of 30 September 2025.
- The company established a Sponsored American Depositary Receipt on the OTCQB Venture Market.
- Top End Energy is leveraging U.S. Executive Orders to enhance its American portfolio.
- Top End Energy's Beetaloo Basin strategy aligns with President Trump's energy development directives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Litchfield Minerals Limited (LMS) ORDINARY FULLY PAID |
Materials |
$35 |
200m Copper-Zinc Zone Demonstrates System Scale & Continuity
|
31 Oct 2025 9:03AM |
$0.675 |
$0.600 |
fallen by
11.11%
|
|
LMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Intersection of 200m of continuous copper-zinc mineralization in hole OGRC014.
- High-grade mineralization includes 59m at ~2% chalcopyrite and ~3% sphalerite.
- Planned step-out drilling aims to extend high-grade continuity to ~600m.
- Use of IP and ground electromagnetics to refine drill targeting.
- 200m vertical continuity demonstrated between OGRC010 and OGRC014.
- Completion of an accelerated, systematic exploration program planned.
- Focus on large system potential beyond Oonagalabi main zone.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$40 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:03AM |
$0.009 |
$0.013 |
risen by
44.44%
|
|
AAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities was $433,000.
- Investments in joint ventures totaled $399,000 for the quarter.
- Cash inflow from financing activities was $1,538,000.
- Binding MoU signed with Shandong Xinhai Mining for Nueva Sabana project.
- La Demajagua project planning for development in 2027-28.
- El Pilar and La Cristina exploration activities scheduled for 2026.
- Cash on hand at quarter end was A$1,829,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$252 |
Appendix 3Y - Michael McNulty
|
31 Oct 2025 9:03AM |
$1.135 |
$0.930 |
fallen by
18.06%
|
|
| Perennial Income Generator Fund (Managed Fund) (EIGA) |
Financials |
$29 |
EIGA Monthly Portfolio Disclosure
|
31 Oct 2025 9:03AM |
$3.760 |
$3.830 |
risen by
1.86%
|
|
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$8 |
Airborne Geophysics Underway at Commonwealth Project
|
31 Oct 2025 9:03AM |
$0.066 |
$0.059 |
fallen by
10.61%
|
|
KNI - Price-sensitive ASX Announcement
Full Release
Key Points
- 328 line-kilometre MobileMT survey to map sulphide zones.
- Advanced electromagnetic imaging for 3D resistivity modelling.
- Geophysical program focuses on the Commonwealth-Silica Hill corridor.
- Community coordination with local landholders for low-impact data acquisition.
- Kuniko is focused on ethical sourcing and energy transition minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| eInvest Better Future (Managed Fund) (IMPQ) |
Financials |
$35 |
IMPQ Monthly Portfolio Disclosure
|
31 Oct 2025 9:02AM |
$5.090 |
$4.540 |
fallen by
10.81%
|
|
| Jindalee Lithium Limited (JLL) ORDINARY FULLY PAID |
Materials |
$59 |
Quarterly Cashflow Report - September 2025
|
31 Oct 2025 9:01AM |
$0.545 |
$0.580 |
risen by
6.42%
|
|
JLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Negative cash flows from operating and investing activities.
- Net cash used in operating activities was AUD 1,024,000.
- Net cash used in investing activities was AUD 861,000.
- Cash and cash equivalents at end of period were AUD 2,099,000.
- Recent AUD 8 million raised through share placement.
- Company remains optimistic about meeting business objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jindalee Lithium Limited (JLL) ORDINARY FULLY PAID |
Materials |
$59 |
Quarterly Activities Report - September 2025
|
31 Oct 2025 9:01AM |
$0.545 |
$0.580 |
risen by
6.42%
|
|
JLL - Price-sensitive ASX Announcement
Full Release
Key Points
- McDermitt Lithium Project designated as a FAST-41 Transparency Project.
- Non-binding LOI with SPAC to raise US$20-30M, listing on a US exchange.
- Value optimization program for magnesium by-products at McDermitt.
- US government support and strategic partnerships being pursued.
- Capital raising of $8 million and proposed equity line of credit of up to US$100M.
- Appointment of Tristan Garthe as Chief Financial Officer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Polymetals Resources Ltd (POL) ORDINARY FULLY PAID |
Materials |
$322 |
Reinstatement to Quotation
|
31 Oct 2025 9:01AM |
$1.245 |
$1.045 |
fallen by
16.06%
|
|
POL - Price-sensitive ASX Announcement
Full Release
Key Points
- Polymetals Resources Ltd (ASX: POL) will have its trading suspension lifted.
- The reinstatement follows an announcement regarding a serious safety incident at the Endeavor Mine Site.
- ASX Compliance issued the announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Gold and Copper Ltd (AGC) ORDINARY FULLY PAID |
Materials |
$57 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:01AM |
$0.180 |
$0.210 |
risen by
16.67%
|
|
AGC - Price-sensitive ASX Announcement
Full Release
Key Points
- AGC executed a binding tenement sale agreement for Browns Reef Project.
- The Browns Reef Project adds 1,269km² to AGC's existing South Cobar holdings.
- AGC conducted aircore and RC drilling, with promising assay results.
- Significant mineralization discovered at Achilles Shear Zone.
- Company remains well-funded with $12.5M cash on-hand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Polymetals Resources Ltd (POL) ORDINARY FULLY PAID |
Materials |
$322 |
Significant Incident Endeavor Mine
|
31 Oct 2025 9:01AM |
$1.245 |
$1.045 |
fallen by
16.06%
|
|
POL - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant incident at the Endeavor Mine involving fatalities.
- Immediate suspension of all operations at the site.
- Investigation into the cause of the incident is ongoing.
- Support extended to affected families and colleagues.
- Planned staged resumption of operations starting 5 November 2025.
- Polymetals' commitment to safety and well-being as a priority.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Visionflex Group Limited (VFX) ORDINARY FULLY PAID |
Health Care |
$8 |
Appendix 4C - Q1 FY26
|
31 Oct 2025 9:00AM |
$0.002 |
$0.096 |
risen by
4,700%
|
|
VFX - Price-sensitive ASX Announcement
Full Release
Key Points
- Visionflex Group Limited reported a net cash outflow from operating activities of $999,000 for the quarter ending on 30 September 2025.
- The company made payments for staff wages amounting to $927,000 and incurred $546,000 in product manufacturing and operating costs.
- Visionflex Group utilized $540,000 from convertible debt securities, with transaction costs of $22,000 related to these financings.
- Cash and cash equivalents at the end of the quarter stood at $1,402,000, maintaining the same balance as the previous quarter.
- The company has a credit standby arrangement of $4,000,000, with $3,000,000 currently drawn down.
- Visionflex is converting $3 million of the facility and $0.25 million of accrued interest into equity, subject to shareholder approval.
- Key financing terms include an interest rate of 11.10% per annum and a line fee of 1% per annum, with provisions for conversion into shares.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peoplein Limited (PPE) ORDINARY FULLY PAID |
Industrials |
$73 |
Update - Notification of buy-back - PPE
|
31 Oct 2025 9:00AM |
$0.850 |
$0.665 |
fallen by
21.76%
|
|